Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Sino Biopharmaceutical ( (HK:1177) ) has shared an announcement.
Sino Biopharmaceutical Limited has announced a change in its Hong Kong branch share registrar and transfer office, effective from March 31, 2025. This change to Tricor Investor Services Limited is expected to streamline the process of share transfer registrations and collection of share certificates, potentially impacting stakeholders by enhancing operational efficiency.
More about Sino Biopharmaceutical
Sino Biopharmaceutical Limited is a company incorporated in the Cayman Islands, primarily operating in the biopharmaceutical industry. It focuses on the development, manufacturing, and sale of a wide range of pharmaceutical products, targeting various therapeutic areas to meet market demands.
YTD Price Performance: 4.82%
Average Trading Volume: 1,865
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $7.75B
For an in-depth examination of 1177 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue